Search

Search Constraints

You searched for: Author/Creator Haarhaus, Mathias

Search Results

1. Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. (November 2019)

2. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA. Issue 3 (2nd November 2020)

3. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D. Issue 1 (24th October 2020)

4. FC086: Improved Immunologic Response to COVID-19 Vaccine with Prolonged Dosing Interval in Hemodialysis Patients. (3rd May 2022)

5. FP330APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS. (13th June 2019)

6. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients. Issue 2 (March 2021)

7. Immunogenicity and tolerability of COVID‐19 vaccination in peritoneal dialysis patients—A prospective observational cohort study. Issue 3 (1st December 2021)

8. Improved immunologic response to COVID‐19 vaccine with prolonged dosing interval in haemodialysis patients. (7th March 2022)